Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Proshares Trust (ZBIO) Invested Capital (2023 - 2025)

Historic Invested Capital for Zenas BioPharma (ZBIO) over the last 3 years, with Q3 2025 value amounting to $196.4 million.

  • Zenas BioPharma's Invested Capital fell 4535.09% to $196.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $196.4 million, marking a year-over-year decrease of 4535.09%. This contributed to the annual value of $312.5 million for FY2024, which is 23842.66% up from last year.
  • Zenas BioPharma's Invested Capital amounted to $196.4 million in Q3 2025, which was down 4535.09% from $239.6 million recorded in Q2 2025.
  • In the past 5 years, Zenas BioPharma's Invested Capital registered a high of $359.4 million during Q3 2024, and its lowest value of -$288.8 million during Q2 2024.
  • Moreover, its 3-year median value for Invested Capital was $196.4 million (2025), whereas its average is $47.0 million.
  • Its Invested Capital has fluctuated over the past 5 years, first skyrocketed by 27773.4% in 2024, then plummeted by 4535.09% in 2025.
  • Over the past 3 years, Zenas BioPharma's Invested Capital (Quarter) stood at -$225.7 million in 2023, then skyrocketed by 238.43% to $312.5 million in 2024, then crashed by 37.13% to $196.4 million in 2025.
  • Its Invested Capital stands at $196.4 million for Q3 2025, versus $239.6 million for Q2 2025 and $284.3 million for Q1 2025.